Hamish Philpott

Hamish Philpott

Adelaide Medical School

Faculty of Health and Medical Sciences


Dr Hamish Philpott is a gastroenterologist and early career researcher who has completed a PhD at Monash University related to eosinophilic esophagitis. Dr Philpott received a NHMRC scholarship to support his PhD studies, and since became the Philip Bushell Foundation Research Travel Award recipient for 2016/17, and has additional research funding from the philanthropic organisation for eosinophilic disease (ausEE). He has >40 research publications, most of which relate to eosinophilic gastrointestinal disease. Dr Philpott returned from the University of North Carolina Chapel Hill in June 2017, and has taken up a staff specialist position in Adelaide (Northern Adelaide Local Health Network/University of Adelaide).

    Expand
  • Journals

    Year Citation
    2019 Philpott, H., Dougherty, M., Torpy, D., & Dellon, E. (2019). Letter: reassuringly normal response to ACTH in children treated with swallowed topical corticosteroids for eosinophilic oesophagitis – authors’ reply. Alimentary Pharmacology and Therapeutics, 49(12), 1539.
    DOI
    2018 Philpott, H., & Dellon, E. (2018). The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?. Journal of Gastroenterology, 53(2), 165-171.
    DOI Scopus9 WoS8 Europe PMC3
    2018 Philpott, H., Dougherty, M., Reed, C., Caldwell, M., Kirk, D., Torpy, D., & Dellon, E. (2018). Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis. Alimentary Pharmacology and Therapeutics, 47(8), 1071-1078.
    DOI Scopus12 WoS11 Europe PMC6
    2018 Ellison, S., & Philpott, H. (2018). A New Paradigm in the Treatment of Eosinophilic Esophagitis: Proton Pump Inhibitors Are Safe, Aim for "Deep Remission". Journal of pediatric gastroenterology and nutrition, 67(2), 146-147.
    DOI
    2018 Sharma, A., & Philpott, H. (2018). Food Bolus Impaction in the Era of Increased EoE Recognition: Push and Pull, Biopsy and Dilate Before It Is Too Late. Digestive Diseases and Sciences, 63(6), 1371-1373.
    DOI
    2018 Philpott, H., & Dellon, E. (2018). Histologic improvement after 6 weeks of dietary elimination for eosinophilic esophagitis may be insufficient to determine efficacy.. Asia Pacific allergy, 8(2), e20.
    DOI
    2018 Shahzad, M., Harding, D., Ruszkiewicz, A., Tran, E., England, G., & Philpott, H. (2018). Gastrointestinal: Olmesartan-induced enteropathy. Journal of Gastroenterology and Hepatology (Australia), 33(10), 1691.
    DOI Scopus1 WoS1
    2018 Philpott, H., Dougherty, M., & Dellon, E. (2018). Letter: screening for adrenal suppression in paediatric inflammatory bowel disease – authors’ reply. Alimentary Pharmacology and Therapeutics, 48(8), 885-886.
    DOI
    2018 Dellon, E., Liacouras, C., Molina-Infante, J., Furuta, G., Spergel, J., Zevit, N., . . . Bredenoord, A. (2018). Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology, 155(4), 1022-1033.e10.
    DOI Scopus43 WoS30 Europe PMC6
    2017 Philpott, H., Garg, M., Tomic, D., Balasubramanian, S., & Sweis, R. (2017). Dysphagia: Thinking outside the box. World Journal of Gastroenterology, 23(38), 6942-6951.
    DOI Scopus5 Europe PMC3
    2017 Tuck, C., Yao, C., Philpott, H., & Barrett, J. (2017). Questioning the Utility of Breath Testing in Clinical Practice. American Journal of Gastroenterology, 112(12), 1886.
    DOI Scopus1 Europe PMC1
    2017 Philpott, H., & Thien, F. (2017). The Role of Allergy Testing in Eosinophilic Esophagitis: an Update of the Evidence.. Current treatment options in gastroenterology, 15(1), 26-34.
    DOI Europe PMC1
    2017 Philpott, H., Kweh, B., & Thien, F. (2017). Eosinophilic esophagitis: Current understanding and evolving concepts. Asia Pacific Allergy, 7(1), 3-9.
    DOI Scopus2 Europe PMC3
    2017 Philpott, H., & Dellon, E. (2017). A Penetrating Look at Eosinophilic Esophagitis Pathogenesis: Direct Antigen Exposure in the Esophagus?. Gastroenterology, 153(2), 605-606.
    DOI
    2017 Philpott, H., & Sweis, R. (2017). Hiatus Hernia as a Cause of Dysphagia. Current Gastroenterology Reports, 19(8), 40.
    DOI
    2017 Yao, C., Tuck, C., Barrett, J., Canale, K., Philpott, H., & Gibson, P. (2017). Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders. United European Gastroenterology Journal, 5(2), 284-292.
    DOI Scopus16
    2016 Philpott, H., Yu, S., & Rao, S. (2016). It's All in the Mix: Diagnosis and Management of Food Intolerance. Clinical Gastroenterology and Hepatology, 14(8), 1221-1222.
    DOI Scopus1 Europe PMC1
    2016 Philpott, H., & Gibson, P. (2016). Letter: dietary therapy in eosinophilic oesophagitis – do not test, just eliminate and reintroduce the most common food triggers. Authors' reply. Alimentary Pharmacology and Therapeutics, 44(8), 905-906.
    DOI Scopus1
    2016 Philpott, H., & Gibson, P. (2016). Letter: avoiding misconceptions about elimination diet for eosinophilic oesophagitis – authors’ reply. Alimentary Pharmacology and Therapeutics, 44(1), 100-101.
    DOI
    2016 Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2016). Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities. Alimentary Pharmacology and Therapeutics, 44(3), 223-233.
    DOI Scopus27 Europe PMC17
    2016 Philpott, H., & Gibson, P. (2016). Editorial: Management of eosinophilic oesophagitis - Efficacy vs. effectiveness. Authors' reply. Alimentary Pharmacology and Therapeutics, 44(2), 199-200.
    DOI
    2016 Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2016). A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis. Alimentary Pharmacology and Therapeutics, 43(9), 985-993.
    DOI Scopus28 Europe PMC23
    2016 Philpott, H., Nandurkar, S., Royce, S., & Gibson, P. (2016). Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis. Journal of Gastroenterology and Hepatology (Australia), 31(3), 590-594.
    DOI Scopus12 Europe PMC9
    2016 Peters, S., Yao, C., Philpott, H., Yelland, G., Muir, J., & Gibson, P. (2016). Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? Authors' reply. Alimentary Pharmacology and Therapeutics, 44(8), 902-903.
    DOI
    2016 Peters, S., Yao, C., Philpott, H., Yelland, G., Muir, J., & Gibson, P. (2016). Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 44(5), 447-459.
    DOI Scopus52 Europe PMC32
    2015 Yao, C., Barrett, J., Philpott, H., Chung, A., van Langenberg, D., Garg, M., & Gibson, P. (2015). Poor predictive value of breath hydrogen response for probiotic effects in IBS. Journal of Gastroenterology and Hepatology (Australia), 30(12), 1731-1739.
    DOI Scopus7 Europe PMC6
    2015 Philpott, H., Nandurkar, S., Thien, F., Gibson, P., & Royce, S. (2015). Eosinophilic esophagitis: A clinicopathological review. Pharmacology and Therapeutics, 146, 12-22.
    DOI Scopus13 Europe PMC10
    2015 Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. (2015). Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndRome. World Journal of Gastroenterology, 21(40), 11379-11386.
    DOI Scopus2 Europe PMC2
    2015 Philpott, H., Nandurkar, S., Royce, S., & Gibson, P. (2015). Letter: Seasonality in eosinophilic oesophagitis and food bolus obstruction - What about recurrent episodes?. Alimentary Pharmacology and Therapeutics, 42(7), 936.
    DOI Scopus2 Europe PMC2
    2015 Philpott, H., Nandurkar, S., Thien, F., Bloom, S., Lin, E., Goldberg, R., . . . Gibson, P. (2015). Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis. Internal Medicine Journal, 45(9), 939-943.
    DOI Scopus21 Europe PMC13
    2015 Philpott, H., Lubel, J., & Nandurkar, S. (2015). Letter: Colestyramine for chronic unexplained diarrhoea - Promising but much to learn?. Alimentary Pharmacology and Therapeutics, 42(3), 388.
    DOI Scopus1 Europe PMC1
    2015 Philpott, H., Royce, S., Thien, F., Nandurkar, S., & Gibson, P. (2015). What gastroenterologists should know about testing patients with eosinophilic esophagitis for food allergies. Clinical Gastroenterology and Hepatology, 13(5), 1029-1030.
    DOI Europe PMC1
    2015 Philpott, H., Royce, S., Nandurkar, S., Thien, F., & Gibson, P. (2015). IgG and EoE: Too soon for a paradigm shift away from IgE. Gastroenterology, 148(2), 453-454.
    DOI Scopus3 Europe PMC3
    2015 Philpott, H., Nandurkar, S., Thien, F., Gibson, P., & Royce, S. (2015). Eosinophilic esophagitis: A clinicopathological review. Pharmacology and Therapeutics, 146, 12-22.
    DOI Scopus4
    2014 Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. (2014). Drug-induced gastrointestinal disorders. Postgraduate Medical Journal, 90(1065), 411-419.
    DOI Scopus10 Europe PMC4
    2014 Philpott, H., Nandurkar, S., Royce, S., Thien, F., & Gibson, P. (2014). Risk factors for eosinophilic esophagitis. Clinical and Experimental Allergy, 44(8), 1012-1019.
    DOI Scopus12 Europe PMC9
    2013 Philpott, H., Gibson, P., Thien, F., & Nandurkar, S. (2013). Letter: An allergic phenotype in patients with eosinophilic oesophagitis and asthma. Alimentary Pharmacology and Therapeutics, 37(7), 755-756.
    DOI Scopus1 Europe PMC1
    2013 Philpott, H., Nandurkar, S., Lubel, J., & Gibson, P. (2013). Alternative investigations for irritable bowel syndrome. Journal of Gastroenterology and Hepatology (Australia), 28(1), 73-77.
    DOI Scopus10 Europe PMC8
    2012 Philpott, H., Gow, P., Crowley, P., Nandurkar, S., Douglass, J., & Gibson, P. R. (2012). Systemic mastocytosis: a gastroenterological perspective.. Frontline gastroenterology, 3(1), 5-9.
    DOI
    2009 Shakib, S., Philpott, H., & Clark, R. (2009). What we have here is a failure to communicate! Improving communication between tertiary to primary care for chronic heart failure patients. Internal Medicine Journal, 39(9), 595-599.
    DOI Scopus8 WoS6 Europe PMC7
    2008 Philpott, H., Kette, F., Hissaria, P., Gillis, D., & Smith, W. (2008). Chronic urticaria: the autoimmune paradigm. Internal Medicine Journal, 38(11), 852-857.
    DOI Scopus13 WoS11 Europe PMC5
    2008 Philpott, H., Hissaria, P., Warren, L., Singhal, N., Brown, M., Proudman, S., . . . Gillis, D. (2008). Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma. Australasian Journal of Dermatology, 49(1), 27-29.
    DOI Scopus13 WoS10 Europe PMC3
    2007 Philpott, H. (2007). A failure to relax. Australian Family Physician, 36(10), 849-850.
    2005 Hay, P., Loukas, A., & Philpott, H. (2005). Prevalence and characteristics of men with eating disorders in primary care: how do they compare to women and what features may aid in identification?. Primary Care & Community Psychiatry, 10(1), 1-6.
    DOI Scopus14 WoS14
  • Conference Papers

    Year Citation
    2017 Philpott, H., & Dellon, E. S. (2017). Solid Organ Transplantation is not a Risk Factor for Eosinophilic Oesophagitis: A Review of 13,792 Transplants Performed on a Predominantly Adult Population in North Carolina. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193). Orlando, FL: NATURE PUBLISHING GROUP.
    2017 Philpott, H., & Dellon, E. S. (2017). Six Weeks May Be Insufficient to Determine the Success of Elimination Diet Based on Histological Parameters Alone in Adults With Eosinophilic Esophagitis. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193). Orlando, FL: NATURE PUBLISHING GROUP.
    2017 Philpott, H., Beitia, R., Barnes, C., Arrington, A., Perjar, I., Hollyfield, J., . . . Dellon, E. S. (2017). Decline in Esophageal Eosinophil Counts can be Substantial in Many Patients With Eosinophilic Esophagitis After Treatment With Proton Pump Inhibitors. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S194). Orlando, FL: NATURE PUBLISHING GROUP.
    2017 Philpott, H., Reed, C. C., Dougherty, M., & Dellon, E. S. (2017). Adrenal Insufficiency Is Rare With Topical Corticosteroid Treatment for Eosinophilic Esophagitis: A Systematic Review. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 112 (pp. S193-S194). Orlando, FL: NATURE PUBLISHING GROUP.

Connect With Me
External Profiles